Cabometyx trial halted early on success in liver cancer

17th January 2018 Uncategorised 0

A late-stage trial assessing Ipsen and Exelixis’ Cabometyx in advanced liver cancer has been halted early after a significant improvement in overall survival was observed.

More: Cabometyx trial halted early on success in liver cancer
Source: News